SavedAdd your journal

Journals / Turkish Journal of Pediatrics / 2020 / Cilt: 62 - Sayı: 6

A case of fulminant pneumococcus meningoencephalitis progressing with white matter involvement despite two doses of conjugated pneumococcus vaccine

Ebru AZAPAĞASI
Tanıl KENDİRLİ
Serhan ÖZCAN
Gökçen Öz TUNCER
Halil ÖZDEMİR
Ömer Suat FİTÖZ
Erdal İNCE
Pages
1058–1063
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Such diffuse white matter lesions among pediatric patients with Streptococcus pneumoniameningoencephalitis despite two doses of PCV have not been reported previously.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Streptococcus pneumonia is a cause of serious mortality and morbidity, especially among small children.
📊
Key Findings & Data:However, currently, it causes lower rates of invasive infections due to successful vaccination programs.Case.
💡
Conclusion & Impact:Such diffuse white matter lesions among pediatric patients with Streptococcus pneumoniameningoencephalitis despite two doses of PCV have not been reported previously.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background. Streptococcus pneumonia is a cause of serious mortality and morbidity, especially among small children. However, currently, it causes lower rates of invasive infections due to successful vaccination programs.Case. We report an exceptional case of a 6-month-old child with meningoencephalitis caused by Streptococcus pneumonia despite the administration of two doses of pneumococcal conjugate vaccine (PCV). Meningitis progressed rapidly and led to widespread damage in parenchymal brain tissue with the emergence of fulminant meningoencephalitis. Computed tomography (CT) and magnetic resonance imaging (MRI) revealed widespread brain lesions, suggesting extensive parenchymal injury. Conclusion. Such diffuse white matter lesions among pediatric patients with Streptococcus pneumoniameningoencephalitis despite two doses of PCV have not been reported previously.

🔖

Cite This Article

AZAPAĞASI, E., KENDİRLİ, T., ÖZCAN, S., TUNCER, G. Ö., ÖZDEMİR, H., FİTÖZ, Ö. S., İNCE, E. (2020). A case of fulminant pneumococcus meningoencephalitis progressing with white matter involvement despite two doses of conjugated pneumococcus vaccine. Turkish Journal of Pediatrics, Cilt: 62 - Sayı: 6, 1058–1063. https://ajindex.com/articles/411910

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bridy-Pappas AE, Margolis MB, Center KJ, Isaacman DJ. Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention. Pharmacotherapy 2005; 25: 1193-1212
  2. Whitney CG, Farley MM, Hadler J, et al; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737-1746
  3. Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007; 369: 1179-1186
  4. Kang SJ, Kim HY, Kim YS, Lee HN, Kim HT, Kim SH. Intractable pneumococcal meningoencephalitis associated with a TNF-α antagonist. J Neurol Sci 2014; 344: 215-218
  5. Jorens PG, Parizel PM, Wojciechowski M, et al. Streptococcus pneumoniae meningoencephalitis with unusual and widespread white matter lesions. Eur J Paediatr Neurol 2008; 12: 127-132
  6. Jorens PG, Parizel PM, Demey HE, et al. Meningoencephalitis caused by Streptococcus pneumoniae: a diagnostic and therapeutic challenge. Diagnosis with diffusion-weighted MRI leading to treatment with corticosteroids. Neuroradiology 2005; 47: 758-764 7. Magnus J, Parizel PM, Ceulemans B, Cras P, Luijks M, Jorens PG. Streptococcus pneumoniae meningoencephalitis with bilateral basal ganglia necrosis: an unusual complication due to vasculitis. J Child Neurol 2011; 26: 1438-1443
  7. Jit M. The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis. J Infect 2010; 61: 114-124
  8. Katchanov J, Heuschmann PU, Endres M, Weber JR. Cerebral infarction in bacterial meningitis: predictive factors and outcome. J Neurol 2010; 257: 716-720
  9. Snyder RD, Stovring J, Cushing AH, Davis LE, Hardy TL. Cerebral infarction in childhood bacterial meningitis. J Neurol Neurosurg Psychiatry 1981; 44: 581-585
  10. Tibussek D, Sinclair A, Yau I, et al. Late-onset group B streptococcal meningitis has cerebrovascular complications. J Pediatr 2015; 166: 1187-1192.e1
  11. Ceyhan M, Ozsurekci Y, Gurler N, et al. Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey. Clin Vaccine Immunol 2013; 20: 972-976
  12. Wittebole X, Duprez T, Hantson P. Delayed cerebral ischaemic injury following apparent recovery from Streptococcus pneumoniae meningitis. Acta